Active Ingredient: LACOSAMIDE
Proprietary Name: LACOSAMIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 200MG/20ML (10MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A216806
Product Number: 001
Approval Date: Apr 5, 2024
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information